Abaxis (ABAX) Declares $0.16 Quarterly Dividend; 1% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2018 and Declares Quarterly Cash Dividend
January 25, 2018 4:01 PM ESTUNION CITY, Calif., Jan. 25, 2018 /PRNewswire/ --Â Abaxis, Inc. (Nasdaq: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, today reported financial results for the third fiscal quarter ended December 31, 2017.
Third quarter results include:
Revenues of $59.7 million, up 13% over last year's comparable quarter. Diluted net income per share of $0.18, compared to $0.30 in last year's comparable quarter. Diluted net income per share for the third quarter of fiscal 2018 includes the effect of a one-time non-cash... More